Abstract
Bypass revascularization helps prevent complications in Moyamoya Disease (MMD). To systematically review complications associated with combined direct and indirect (CB) bypass in MMD and analyze differences between the adult and pediatric populations. A systematic literature review was conducted per PRISMA guidelines. PUBMED, Cochrane Library, Web of Science, and CINAHL, were queried from January 1980 to March 2022. Complications were defined as any event in the immediate post-surgical period of a minimum 3 months follow-up. Exclusion criteria included lack of surgical complication reports, non-English articles, and CB unspecified or reported separately. 18 final studies were included of 1580 procured. 1151 patients (per study range = 10—150, mean = 63.9) were analyzed. 9 (50.0%) studies included pediatric patients. There were 32 total hemorrhagic, 74 total ischemic and 16 total seizure complications, resulting in a rate of 0.04 (95% CI 0.03, 0.06), 0.7 (95% CI 0.04, 0.10) and 0.03 (95% CI 0.02, 0.05), respectively. The rate of hemorrhagic complications in the pediatric showed no significant difference from the adult subgroup (0.03 (95% CI 0.01—0.08) vs. 0.06 (95% CI 0.04—0.10, p = 0.19), such as the rate of ischemic complications (0.12 (95% CI 0.07—0.23) vs. 0.09 (95% CI 0.05—0.14, p = 0.40). Ischemia is the most common complication in CB for MMD. Pediatric patients had similar hemorrhagic and ischemic complication rates compared to adults.
Similar content being viewed by others
Data availability
Not applicable.
References
Acker G, Fekonja L, Vajkoczy P (2018) Surgical management of moyamoya disease. Stroke 49(2):476–482. https://doi.org/10.5853/jos.2015.01627
Amin-hanjani S, Singh A, Rifai H, Thulborn KR et al (2013) Combined direct and indirect bypass for moyamoya. Neurosurgery 73(6):962–968. https://doi.org/10.1227/neu.0000000000000139
Chen Z, Zhang L, Qu J, Wu Y et al (2018) Clinical analysis of combined revascularization in treating ischemic moyamoya disease in adults. Neurochirurgie 64(1):49–52. https://doi.org/10.1016/j.neuchi.2017.08.005
Cho WS, Chung YS, Kim JE et al (2015) The natural clinical course of hemodynamically stable adult moyamoya disease. J Neurosurg 122(1):82–89. https://doi.org/10.3171/2014.9.jns132281
Cho WS, Kim JE, Kim CH, Ban SP, Kang HS, Son YJ et al (2014) Long-term outcomes after combined revascularization surgery in adult moyamoya disease. Stroke 45(10):3025–3031. https://doi.org/10.1161/strokeaha.114.005624
Choi JU, Kim DS, Kim EY, Lee KC (1997) Natural history of moyamoya disease: Comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg 99(2):11–18. https://doi.org/10.1016/s0303-8467(97)00033-4
Czabanka M, Peña-Tapia P, Scharf J, Schubert GA, Münch E, Horn P et al (2011) Characterization of direct and indirect cerebral revascularization for the treatment of European patients with moyamoya disease. Cerebrovasc Dis 32(4):361–369. https://doi.org/10.1159/000330351
Demartini Z Jr, Teixeira BC, Koppe GL, Gatto LAM, Roman A, Munhoz RP (2022) Moyamoya disease and syndrome: A review. Radiol Bras 55(1):31–37. https://doi.org/10.1590/0100-3984.2021.0010
Deng X, Gao F, Zhang D, Zhang Y, Wang R, Wang S, Cao Y, Zhao Y, Pan Y, Ye X, Liu X, Zhang Q, Wang J, Yang Z, Zhao M, Zhao J (2018) Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: A prospective cohort study. J Neurosurg 128(5):1327–1337. https://doi.org/10.3171/2016.12.jns162626
Fujimura M, Tominaga T (2012) Lessons learned from moyamoya disease: Outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo) 52(5):327–332. https://doi.org/10.2176/nmc.52.327
Fujita K, Tamaki N, Matsumoto S (1986) Surgical treatment of moyamoya disease in children: Which is more effective procedure, EDAS or EMS? Childs Nerv Syst 2(3):134–138. https://doi.org/10.1007/bf00270841
Fung LW, Thompson D, Ganesan V (2005) Revascularisation surgery for paediatric moyamoya: A review of the literature. Childs Nerv Syst 21(5):358–364. https://doi.org/10.1007/s00381-004-1118-9
Gross BA, Du R (2013) The natural history of moyamoya in a North American adult cohort. J Clin Neurosci 20(1):44–48. https://doi.org/10.1016/j.jocn.2012.08.002
Hertza J, Loughan A, Perna R, Davis AS, Segraves K, Tiberi NL (2014) Moyamoya disease: A review of the literature. Appl Neuropsychol Adult 21(1):21–27. https://doi.org/10.1080/09084282.2012.721147
Houkin K, Kamiyama H, Takahashi A, Kuroda S et al (1997) Combined revascularization surgery for childhood moyamoya disease: STA-MCA and encephalo-duro-arterio-myo-synangiosis. Childs Nerv Syst 13(1):24–29. https://doi.org/10.1007/s003810050034
Isono M, Ishii K, Kamida T, Inoue R, Fujiki M, Kobayashi H (2002) Long-term outcomes of pediatric moyamoya disease treated by encephalo-duro-arterio-synangiosis. Pediatr Neurosurg 36(1):14–21. https://doi.org/10.1159/000048343
Jiang H, Ni W, Xu B, Lei Y, Tian Y, Xu F, Gu Y, Mao Y (2014) Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass. J Neurosurg 121(5):1048–1055. https://doi.org/10.3171/2014.7.jns132434
Karasawa J, Kikuchi H, Furuse S, Kawamura J, Sakaki T (1978) Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg 49(5):679–688. https://doi.org/10.3171/jns.1978.49.5.0679
Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H (1992) Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg 77(1):84–89. https://doi.org/10.3171/jns.1992.77.1.0084
Kim JS (2016) Moyamoya disease: Epidemiology, clinical features, and diagnosis. J Stroke 18(1):2–11. https://doi.org/10.5853/jos.2015.01627
Kim KM, Kim JE, Cho WS, Kang HS, Son YJ, Han MH, Oh CW (2017) Natural history and risk factor of recurrent hemorrhage in hemorrhagic adult moyamoya disease. Neurosurgery 81(2):289–296. https://doi.org/10.1093/neuros/nyw179
Kim SH, Lee H, Yoo M, Jin S et al (2019) Angiographic and clinical outcomes of non-patent anastomosis after bypass surgery in adult moyamoya disease. Acta Neurochir (Wien) 161(2):379–384. https://doi.org/10.1007/s00701-018-3733-3
Kuroda S, Nakayama N, Yamamoto S, Kashiwazaki D et al (2020) Late (5–20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease. J Neurosurg 134(3):909–916. https://doi.org/10.3171/2019.12.jns192938
Nguyen VN, Motiwala M, Elarjani T et al (2022) Direct, indirect, and combined extracranial-to-intracranial bypass for adult moyamoya disease: An updated systematic review and meta-analysis. Stroke 53(12):3572–3582. https://doi.org/10.1161/STROKEAHA.122.039584
Patel NN, Mangano FT, Klimo P Jr (2010) Indirect revascularization techniques for treating moyamoya disease. Neurosurg Clin N Am 21(3):553–563. https://doi.org/10.1016/j.nec.2010.03.008
Rashad S, Fujimura M, Niizuma K, Endo H et al (2016) Long-term follow-up of pediatric moyamoya disease treated by combined direct–indirect revascularization surgery: Single institute experience with surgical and perioperative management. Neurosurg Rev 39(4):615–623. https://doi.org/10.1007/s10143-016-0734-7
Ravina K, Kim PE, Rennert RC, Wolfswinkel EM et al (2019) Lessons learned from the initial experience with pedicled temporoparietal fascial flap for combined revascularization in moyamoya angiopathy: A case series. World Neurosurg 132:259–273. https://doi.org/10.1016/j.wneu.2019.08.182
Ravindran K, Wellons JC, Dewan MC (2019) Surgical outcomes for pediatric moyamoya: A systematic review and meta-analysis. J Neurosurg Pediatr 13:1–10. https://doi.org/10.3171/2019.6.peds19241
Sakamoto T, Kawaguchi M, Kurehara K, Kitaguchi K, Furuya H, Karasawa J (1997) Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease. Anesth Analg 85(5):1060–1065. https://doi.org/10.1097/00000539-199711000-00018
Smith ER, Scott RM (2010) Moyamoya: Epidemiology, presentation, and diagnosis. Neurosurg Clin N Am 21(3):543–551. https://doi.org/10.1016/j.nec.2010.03.007
Starke RM, Komotar RJ, Hickman ZL, Paz YE, Pugliese AG, Otten ML, Garrett MC, Elkind MSV, Marshall RS, Festa JR, Meyers PM, Connolly ES Jr (2009) Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clin Article J Neurosurg 111(5):936–942. https://doi.org/10.3171/2009.3.jns08837
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M et al (2016) ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:4919. https://doi.org/10.1136/bmj.i4919
Uchino K, Johnston SC, Becker KJ, Tirschwell DL (2005) Moyamoya disease in Washington State and California. Neurology 65(6):956–958. https://doi.org/10.1212/01.wnl.0000176066.33797.82
Xu B, Song DL, Mao Y, Gu YX, Xu H, Liao YJ, Liu CH, Zhou LF (2012) Superficial temporal artery-middle cerebral artery bypass combined with encephalo-duro-myo-synangiosis in treating moyamoya disease: Surgical techniques, indications and midterm follow-up results. Chin Med J (Engl) 125(24):4398–4405
Zhao J, Liu H, Zou Y, Zhang W et al (2018) Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: A retrospective study of 76 procedures. Exp Ther Med 15(4):3570–3576. https://doi.org/10.3892/etm.2018.5850
Zhao Y, Yu S, Lu J, Yu L, Li J, Zhang Y, Zhang D, Wang R, Zhao Y (2018) Direct bypass surgery vs. combined bypass surgery for hemorrhagic moyamoya disease: A comparison of angiographic outcomes. Front Neurol 9:1121. https://doi.org/10.3389/2Ffneur.2018.01121
Acknowledgements
No financial funding or support was received for this project. No additional financial disclosures.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Albert M. Isaacs, Anthony E. Bishay, Dillan Amaral, Jhon E. Bocanegra-Becerra, Livia V. Abreu, Michael Dewan, Sávio Batista and Stefan Koester. The first draft of the manuscript was written by Anthony E. Bishay, Dan Zimelewicz Oberman, Raphael Bertani, Sávio Batista and Stefan Koester, and all authors commented on previous versions of the manuscript. Supervision was coordinated by Eberval Gadelha Figueiredo. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Prior presentation
No portion of this data has been presented before.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Batista, S., Koester, S., Bishay, A.E. et al. Complications associated with combined direct and indirect bypass in Moyamoya Disease: A meta-analysis. Neurosurg Rev 47, 58 (2024). https://doi.org/10.1007/s10143-024-02285-4
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10143-024-02285-4